165 related articles for article (PubMed ID: 25153774)
1. The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma.
Psutka SP; Boorjian SA; Lohse CM; Stewart SB; Tollefson MK; Cheville JC; Leibovich BC; Thompson RH
Urol Oncol; 2015 Feb; 33(2):67.e15-23. PubMed ID: 25153774
[TBL] [Abstract][Full Text] [Related]
2. The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy.
Viers BR; Houston Thompson R; Psutka SP; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK; Boorjian SA
Urol Oncol; 2015 Sep; 33(9):388.e11-8. PubMed ID: 25700974
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
[TBL] [Abstract][Full Text] [Related]
4. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinoma.
Psutka SP; Stewart SB; Boorjian SA; Lohse CM; Tollefson MK; Cheville JC; Leibovich BC; Thompson RH
J Urol; 2014 Dec; 192(6):1620-7. PubMed ID: 24931804
[TBL] [Abstract][Full Text] [Related]
6. Metformin Use in Relation With Survival Outcomes of Patients With Renal Cell Carcinoma.
Cheng JJ; Li H; Tan HS; Tan PH; Ng LG; Ng QS; Toh CK; Kanesvaran R; Tan MH
Clin Genitourin Cancer; 2016 Apr; 14(2):168-75. PubMed ID: 26794391
[TBL] [Abstract][Full Text] [Related]
7. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
[TBL] [Abstract][Full Text] [Related]
8. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
9. Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score Analysis.
Nayan M; Finelli A; Jewett MA; Juurlink DN; Austin PC; Kulkarni GS; Hamilton RJ
Clin Genitourin Cancer; 2017 Apr; 15(2):300-305. PubMed ID: 27424258
[TBL] [Abstract][Full Text] [Related]
10. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
Linder BJ; Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Gastineau DA; Boorjian SA
BJU Int; 2014 Sep; 114(3):368-74. PubMed ID: 24471825
[TBL] [Abstract][Full Text] [Related]
11. Management of comorbidities in diabetics with renal cell carcinoma: past utilization and current outcomes.
Rabey JL; Yin J; Kublas TM; Mashtare T; Ceacareanu AC
J Pharm Pract; 2014 Feb; 27(1):31-9. PubMed ID: 23966283
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
[TBL] [Abstract][Full Text] [Related]
13. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
14. Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC).
Cotta BH; Meagher MF; Patil D; Saito K; Patel SH; Patel DN; Miller N; Dutt R; Keiner C; Bradshaw AW; Wan F; Eldefrawy A; Yasuda Y; Fujii Y; Master V; Derweesh IH
BJU Int; 2021 Mar; 127(3):311-317. PubMed ID: 32772468
[TBL] [Abstract][Full Text] [Related]
15. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
16. Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus.
Abel EJ; Carrasco A; Karam J; Tamboli P; Delacroix S; Vaporciyan AA; Wood CG
BJU Int; 2014 Nov; 114(5):667-73. PubMed ID: 24128265
[TBL] [Abstract][Full Text] [Related]
17. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
[TBL] [Abstract][Full Text] [Related]
18. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
19. Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy.
Viers BR; Houston Thompson R; Boorjian SA; Lohse CM; Leibovich BC; Tollefson MK
Urol Oncol; 2014 Nov; 32(8):1277-84. PubMed ID: 25017696
[TBL] [Abstract][Full Text] [Related]
20. The 1-year decline in estimated glomerular filtration rate (eGFR) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same.
Hew MN; Opondo D; Cordeiro ER; van Donselaar-van der Pant KA; Bemelman FJ; Idu MM; de la Rosette JJ; Laguna MP
BJU Int; 2014 May; 113(5b):E49-55. PubMed ID: 24053637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
